Skip to main navigation Skip to main content Skip to page footer


Professor, Section of Pharmaceutical Chemistry

Full CV



  • Degree: BScinPharmacy, UniversityofPatras, (1985-1989) 
  • Doctorate: PhD in Pharmacology, Medical College of Georgia, GA, USA (1990-1994) 
  • Post doctoral training: Vascular Biology Center, Medical College of Georgia, USA; (1994-1995)
  • Boyer Center for Molecular Medicine, Yale University School of Medicine; 1995-1998


  • Undergraduate courses/labs: Pharmacology I, Pharmacology II, Molecular Pharmacology 
  • Graduate courses: Biochemical and molecular Pharmacology, Advanced Pharmacology, Molecular Pharmacology-oxidative stress

Research topics

  • Preclinical drug screening 
  • Molecular Pharmacology
  • Cardiovascular Pharmacology 
  • Cellsignalingandvascularbiology 
  • Gasotransmitters (ΝΟ και H2S)


  • PhD in Pharmacology with Distinction, Medical College of Georgia
  • Fellow of the American Heart Association
  • Fellow of the British Pharmacological Society
  • Most influential Greek Scientist list (by Prof. Ioannidis, ISBN 978-960-04-4489-6)
  • Top 1% of scientists in all fields based on citations doi: 10.1371/journal.pbio.3000384.
  • Visiting Professor UMDNJ, UTMB, LSU, Maastricht University and McGill University 
  • British Journal of Pharmacology, Editorial board member (2009-2018)
  • Arteriosclerosis, Thrombosis and Vascular Biology, Editorial board member  (2010-present)
  • Journal of Pharmacology & Experimental Therapeutics, Editorial board member member  (2012-present)
  • European Network of Gasotrnsmitters, Chair
  • Secretary General, European Federation of Pharmacological Societies, 2016-2020
  • European Medicines Agency, Pediatric Committee National Delegate

Recent publications

  • SIBibli, JHu, FSigala, IWittig, JHeidler, SZukunft, DTsilimigras, VRandriamboavonjy, JWittig, BKojonazarov, CSchürmann, MSiragusa, DSiuda, BLuck, RAbdelMalik, KFilis, GZografos, CChen, DWang, JPfeilschifter, RBrandes, CSzabo, APapapetropoulos, IFleming. Cystathionine-γ lyase sulfhydrates the RNA binding protein HuR to preserve endothelial cell function and delay atherogenesis. Circulation 39:101-114, 2019
  • SI Bibli, Z Zhou, S Zukunft, B Fisslthaler,  I Andreadou, C Szabo, P Brouckaert, I Fleming, A Papapetropoulos. Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischemic insult: role of PYK2 Cardiovasc Res. 113:926-937, 2017.
  • SI Bibli, C Szabo, A Chatzianastasiou, B Luck, S Zukunft, I Fleming, A Papapetropoulos. Hydrogen sulfide preserves eNOS function by inhibiting PYK2: implications for cardiomyocyte survival and cardioprotection. Mol. Pharm. 92:718-730, 2017.
  • M von Wantoch Rekowski, V Kumar, Z Zhou, J Moschner, A Marazioti, M Bantzi, GA Spyroulias, F van den Akker, A Giannis, A Papapetropoulos. Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics. J. Med. Chem. 56, 8948-52, 2013
  • C Szabo, C Coletta, C Chao, K Módis., B Szczesny, A Papapetropoulos, MR Hellmich. Tumor-derived H2S, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation and angiogenesis in colon cancer. Proc Natl Acad Sci USA 110:12474-9, 2013


Andreas Papapetropoulos, B.Pharm, Ph.D., F.A.H.A., FBPharmacolS
Professor of Pharmacology
Faculty of Pharmacy
Department of Pharmaceutical Chemistry
University of Athens
University Campus, Zografou
Athens 15771 Greece
Tel (+30)210-7274786
Fax: (+30) 210 727-4747